A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Conditions
Cancer · Advanced Cancer · Locally Advanced Carcinoma · Metastatic Solid Tumor · Breast Cancer · Prostate Cancer · Colorectal Cancer · Pancreatic Cancer · Liver Cancer · Angiosarcoma · Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Diana Hanna, MD)Florida Cancer Specialist, Sarasota, Florida, United States
Contact: Principal Investigator (Judy Wang, MD)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Saiama Waqar, MD)Sarah Cannon Research Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Meredith P Pelster, MD)NEXT Oncology, San Antonio, Texas, United States
Contact: Principal Investigator (Ismael Rodriguez Rivera, MD)NEXT Oncology, Fairfax, Virginia, United States
Contact: Principal Investigator (Alexander Spira, MD)
Study leads
Glen Weiss, MD
Study Director
Medical Lead